Connect with us

Health & Fitness

Opposing Views for Withdrawal of Approval of Preterm Drug

The results of the required postapproval confirmatory PROLONG trial produced conflicting results, failing to show a benefit of 17OHP on either preterm birth or neonatal outcome. Medscape Medical News

Published

on

Opposing Views for Withdrawal of Approval of Preterm Drug

The results of the required postapproval confirmatory PROLONG trial produced conflicting results, failing to show a benefit of 17OHP on either preterm birth or neonatal outcome. Medscape Medical News
Read More